M. K. Proteins Limited (NSE:MKPL)
4.200
+0.030 (0.72%)
Jul 31, 2026, 3:29 PM IST
M. K. Proteins Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,569 | 1,453 | 2,260 | 3,697 | 9,134 | 799 | |
Market Cap Growth | -40.54% | -35.71% | -38.88% | -59.52% | 1043.60% | 140.88% |
Enterprise Value | 1,936 | 1,429 | 2,076 | 3,740 | 9,502 | 708 |
Last Close Price | 4.18 | 3.87 | 6.02 | 9.85 | 24.33 | 2.13 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.22 | 21.27 | 26.91 | 32.98 | 83.53 | 7.84 |
PS Ratio | 0.41 | 0.38 | 0.84 | 1.51 | 2.90 | 0.31 |
PB Ratio | 2.06 | 1.90 | 3.25 | 6.05 | 18.32 | 2.02 |
P/TBV Ratio | 2.06 | 1.90 | 3.25 | 6.05 | 18.32 | 2.02 |
P/FCF Ratio | 44.34 | 41.05 | - | 13.95 | - | - |
P/OCF Ratio | 28.88 | 26.74 | - | 11.41 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.51 | 0.37 | 0.78 | 1.52 | 3.02 | 0.28 |
EV/EBITDA Ratio | 16.58 | 12.24 | 16.80 | 22.14 | 54.64 | 4.51 |
EV/EBIT Ratio | 17.22 | 12.71 | 17.20 | 22.77 | 57.13 | 4.78 |
EV/FCF Ratio | 54.71 | 40.38 | - | 14.11 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.49 | 0.49 | 0.56 | 0.33 | 0.91 | 0.93 |
Debt / EBITDA Ratio | 3.18 | 3.18 | 3.12 | 1.18 | 2.61 | 2.34 |
Debt / FCF Ratio | 10.50 | 10.50 | - | 0.76 | - | - |
Net Debt / Equity Ratio | 0.48 | 0.48 | 0.56 | 0.33 | 0.91 | 0.93 |
Net Debt / EBITDA Ratio | 3.14 | 3.14 | 3.13 | 1.18 | 2.62 | 2.34 |
Net Debt / FCF Ratio | 10.37 | 10.37 | -2.11 | 0.75 | -7.73 | -3.14 |
Asset Turnover | 2.93 | 2.93 | 2.36 | 2.46 | 3.33 | 3.34 |
Inventory Turnover | 3.33 | 3.33 | 2.51 | 2.70 | 4.37 | 5.45 |
Quick Ratio | 0.05 | 0.05 | 0.11 | 0.19 | 0.36 | 0.70 |
Current Ratio | 2.25 | 2.25 | 2.01 | 2.53 | 1.99 | 1.88 |
Return on Equity (ROE) | 9.37% | 9.37% | 12.87% | 20.21% | 24.44% | 29.54% |
Return on Assets (ROA) | 5.37% | 5.37% | 6.65% | 10.29% | 10.98% | 12.05% |
Return on Invested Capital (ROIC) | 8.87% | 7.39% | 9.35% | 13.49% | 14.13% | 16.40% |
Return on Capital Employed (ROCE) | 14.30% | 14.30% | 16.90% | 26.40% | 31.00% | 34.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.35% | 4.70% | 3.72% | 3.03% | 1.20% | 12.75% |
FCF Yield | 2.26% | 2.44% | -8.12% | 7.17% | -0.64% | -14.64% |
Buyback Yield / Dilution | -1.07% | -1.07% | - | - | - | -0.01% |